Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Balaxi Pharmaceuticals Revenue

Balaxi Pharmaceuticals had revenue of 732.91M INR in the quarter ending December 31, 2024, with 20.57% growth. This brings the company's revenue in the last twelve months to 2.76B, up 5.34% year-over-year. In the fiscal year ending March 31, 2024, Balaxi Pharmaceuticals had annual revenue of 2.41B, down -28.28%.

• Revenue (ttm): 2.76B
• Revenue Growth: +5.34%
• P/S Ratio: 1.40
• Revenue / Employee: 4.60M
• Employees: 600
• Market Cap: 3.60B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	2.41B	-951.38M	-28.28%
Mar 31, 2023	3.36B	570.45M	20.42%
Mar 31, 2022	2.79B	480.55M	20.77%
Mar 31, 2021	2.31B	1.86B	406.95%
Mar 31, 2020	456.33M	316.57M	226.51%